Metabolic-associated fatty liver disease is associated with colorectal adenomas in young and older Korean adults
- PMID: 37735984
- DOI: 10.1111/liv.15738
Metabolic-associated fatty liver disease is associated with colorectal adenomas in young and older Korean adults
Abstract
Background and aims: Given that the majority of colorectal cancers (CRCs) develop from high-risk adenomas, identifying risk factors for high-risk adenomas is important. The relationship between metabolic dysfunction-associated fatty liver disease (MAFLD) and the risk of colorectal adenoma in young adults remains unclear. We aimed to evaluate this relationship in adults <50 (younger) and ≥50 (older) years of age.
Methods: This cross-sectional study included 184 792 Korean adults (80% <50 years of age) who all underwent liver ultrasound and colonoscopy. Participants were grouped into those with and without MAFLD and classified by adenoma presence into no adenoma, low-risk adenoma, or high-risk adenoma (defined as ≥3 adenomas, any ≥10 mm, or adenoma with high-grade dysplasia/villous features).
Results: The prevalence of low- and high-risk adenomas among young and older adults was 9.6% and 0.8% and 22.3% and 4.8%, respectively. MAFLD was associated with an increased prevalence of low- and high-risk adenomas in young and older adults. Young adults with MAFLD had a 1.30 (95% CIs 1.26-1.35) and 1.40 (1.23-1.59) times higher prevalence of low- and high-risk adenomas, respectively, compared to those without MAFLD. These associations were consistent even in lean adults (BMI < 23 kg/m2 ) and those without a family history of CRC.
Conclusions: MAFLD is associated with an increased prevalence of low- and high-risk adenomas in Korean adults, regardless of age or obesity status. Whether reducing metabolic risk factors, such as MAFLD, reduces the risk of precancerous lesions and ultimately reduces the risk of early-onset CRC requires further investigation.
Keywords: metabolic dysfunction-associated fatty liver disease; obesity; young-onset colorectal adenoma.
© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
Non-Obese MAFLD Is Associated with Colorectal Adenoma in Health Check Examinees: A Multicenter Retrospective Study.Int J Mol Sci. 2021 May 22;22(11):5462. doi: 10.3390/ijms22115462. Int J Mol Sci. 2021. PMID: 34067258 Free PMC article.
-
Prevalence of colorectal adenomas in asymptomatic young adults: a window to early intervention?Scand J Gastroenterol. 2016;51(6):731-8. doi: 10.3109/00365521.2015.1130163. Epub 2016 Jan 14. Scand J Gastroenterol. 2016. PMID: 26863602
-
The Risk of Colorectal Adenoma in Nonalcoholic or Metabolic-Associated Fatty Liver Disease.Biomedicines. 2021 Oct 5;9(10):1401. doi: 10.3390/biomedicines9101401. Biomedicines. 2021. PMID: 34680518 Free PMC article.
-
Association between nonalcoholic fatty liver disease and colorectal tumours in asymptomatic adults undergoing screening colonoscopy: a systematic review and meta-analysis.Metabolism. 2018 Oct;87:1-12. doi: 10.1016/j.metabol.2018.06.004. Epub 2018 Jun 20. Metabolism. 2018. PMID: 29935236
-
A Review of the Management of Sporadic Colorectal Adenomas in Young People: Is Surveillance Wasted on the Young?Dig Dis Sci. 2019 Aug;64(8):2107-2112. doi: 10.1007/s10620-019-05521-w. Epub 2019 Feb 20. Dig Dis Sci. 2019. PMID: 30788685 Review.
Cited by
-
Nonalcoholic or metabolic-associated fatty liver disease and colorectal polyps: evidence from meta-analysis and two-sample Mendelian randomization.Front Genet. 2024 Aug 9;15:1422827. doi: 10.3389/fgene.2024.1422827. eCollection 2024. Front Genet. 2024. PMID: 39184353 Free PMC article.
References
REFERENCES
-
- Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249. doi:10.3322/caac.21660
-
- Siegel RL, Torre LA, Soerjomataram I, et al. Global patterns and trends in colorectal cancer incidence in young adults. Gut. 2019;68(12):2179-2185. doi:10.1136/gutjnl-2019-319511
-
- Brenner H, Altenhofen L, Stock C, Hoffmeister M. Natural history of colorectal adenomas: birth cohort analysis among 3.6 million participants of screening colonoscopy. Cancer Epidemiol Biomarkers Prev. 2013;22(6):1043-1051. doi:10.1158/1055-9965.Epi-13-0162
-
- Abu-Freha N, Katz LH, Kariv R, et al. Post-polypectomy surveillance colonoscopy: comparison of the updated guidelines. United European Gastroenterol J. 2021;9(6):681-687. doi:10.1002/ueg2.12106
-
- Sekiguchi M, Matsuda T, Hotta K, Saito Y. Post-polypectomy surveillance: the present and the future. Clin Endosc. 2022;55(4):489-495. doi:10.5946/ce.2022.097
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical